Regis Healthcare Limited
Regis Healthcare Limited Fundamental Analysis
Regis Healthcare Limited (REG.AX) shows weak financial fundamentals with a PE ratio of 48.87, profit margin of 3.03%, and ROE of -1.63%. The company generates $1.3B in annual revenue with strong year-over-year growth of 13.68%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of -122.7/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze REG.AX's fundamental strength across five key dimensions:
Efficiency Score
WeakREG.AX struggles to generate sufficient returns from assets.
Valuation Score
ModerateREG.AX shows balanced valuation metrics.
Growth Score
ModerateREG.AX shows steady but slowing expansion.
Financial Health Score
ModerateREG.AX shows balanced financial health with some risks.
Profitability Score
WeakREG.AX struggles to sustain strong margins.
Key Financial Metrics
Is REG.AX Expensive or Cheap?
P/E Ratio
REG.AX trades at 48.87 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, REG.AX's PEG of -2.61 indicates potential undervaluation.
Price to Book
The market values Regis Healthcare Limited at -62.07 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 12.10 times EBITDA. This signals the market has high growth expectations.
How Well Does REG.AX Make Money?
Net Profit Margin
For every $100 in sales, Regis Healthcare Limited keeps $3.03 as profit after all expenses.
Operating Margin
Core operations generate 3.17 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $-1.63 in profit for every $100 of shareholder equity.
ROA
Regis Healthcare Limited generates $1.46 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Regis Healthcare Limited generates strong operating cash flow of $390.03M, reflecting robust business health.
Free Cash Flow
Regis Healthcare Limited generates strong free cash flow of $233.91M, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $0.77 in free cash annually.
FCF Yield
REG.AX converts 12.53% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
48.87
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-2.61
vs 25 benchmark
P/B Ratio
Price to book value ratio
-62.07
vs 25 benchmark
P/S Ratio
Price to sales ratio
1.48
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
-0.27
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.09
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
-1.63
vs 25 benchmark
ROA
Return on assets percentage
0.01
vs 25 benchmark
ROCE
Return on capital employed
-2.22
vs 25 benchmark
How REG.AX Stacks Against Its Sector Peers
| Metric | REG.AX Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 48.87 | 27.91 | Worse (Expensive) |
| ROE | -162.99% | 687.00% | Weak |
| Net Margin | 3.03% | -45285.00% (disorted) | Weak |
| Debt/Equity | -0.27 | 0.33 | Strong (Low Leverage) |
| Current Ratio | 0.09 | 2795.76 | Weak Liquidity |
| ROA | 1.46% | -13557.00% (disorted) | Weak |
REG.AX outperforms its industry in 1 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Regis Healthcare Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
72.78%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
6925.95%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
140.21%
Industry Style: Defensive, Growth, Innovation
High Growth